Atogepant Efficacious for Patients With Chronic Migraine

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, June 26, 2024 -- For patients with chronic migraine (CM), with and without medication overuse, atogepant is efficacious, according to a study published online June 27 in Neurology.

Peter J. Goadsby, M.D., Ph.D., from King's College London, and colleagues examined the efficacy of atogepant for the preventive treatment of CM in participants with and without acute medication overuse. Participants had at least a one-year history of CM, ≥15 monthly headache days (MHDs), and at least eight monthly migraine days (MMDs) during the four-week baseline period, and were randomly allocated to receive placebo, atogepant 30 mg twice daily (BID), or atogepant 60 mg once daily (QD) for 12 weeks.

The researchers found that 66.2 percent of the 755 participants in the modified intent-to-treat population met the criteria for baseline acute medication overuse. The least squares mean difference (LSMD) in MMDs was -2.7 and -1.9 for atogepant 30 mg BID and atogepant 60 mg QD, respectively, from placebo. There were reductions observed in mean MHDs (LSMD, −2.8 and −2.1, respectively) and mean acute medication use days (LSMD, −2.8 and −2.6, respectively), while an increase was seen in the proportion that achieved ≥50 percent reduction in MMDs (odds ratios, 2.5 and 2.3 with atogepant 30 mg BID and atogepant 60 mg QD, respectively). The proportion of atogepant-treated participants meeting acute medication overuse criteria decreased 52.1 to 61.9 percent over 12 weeks. Patient-reported outcome measures improved with atogepant.

"Treatment with atogepant may potentially decrease the risk of developing rebound headache by reducing the use of pain medications," Goadsby said in a statement.

Several authors disclosed ties to biopharmaceutical companies, including AbbVie, which manufactures atogepant and funded the study.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-06-27 07:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords